<DOC>
	<DOCNO>NCT00002394</DOCNO>
	<brief_summary>The purpose study see safe effective give Lamisil HIV-positive patient thrush ( fungal infection ) respond fluconazole .</brief_summary>
	<brief_title>Safety Effectiveness Giving Lamisil HIV-Positive Subjects With Thrush Who Have Not Responded Fluconazole Treatment</brief_title>
	<detailed_description>This open-label , dose-escalating study 2 sequential cohort . The first 15 patient receive Lamisil 2 week . After 2 week , patient consider clinically cure ( i.e. , absence removable , white plaque ) remove treatment ; patient consider clinically cure receive additional 2 week treatment . At end 4 week , treatment discontinue , regardless clinical cure outcome . If less 80 % patient clinically cure 4 week treatment , second cohort 15 patient receive Lamisil treatment regimen first cohort ( i.e. , initial 2-week treatment period , additional 2 week treatment patient consider clinically cured 2 week treatment ) .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Oral</mesh_term>
	<mesh_term>Terbinafine</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are least 18 year old . Have thrush respond least 10 day fluconazole treatment . Are HIVpositive . Are expected live least 4 week . Are able take oral medication . Exclusion Criteria You eligible study : Have liver kidney disease . Have receive certain medication . Have history serious diarrhea digestive problem . Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1999</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Antifungal Agents</keyword>
	<keyword>Candidiasis , Oral</keyword>
	<keyword>Drug Administration Schedule</keyword>
	<keyword>terbinafine</keyword>
</DOC>